Single nucleotide polymorphism of PIK3CA and its interaction with the environment are risk factors for Chinese Han ovarian cancer
The PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are found in a variety of human cancers. This study aimed to analyze the effect of interactions between PIK3CA rs2699887, rs3976507, rs6443626 single...
Saved in:
Published in | Pathology, research and practice Vol. 215; no. 9; p. 152520 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Germany
Elsevier GmbH
01.09.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are found in a variety of human cancers. This study aimed to analyze the effect of interactions between PIK3CA rs2699887, rs3976507, rs6443626 single nucleotide polymorphisms (SNPs), and the environment on the risk of Chinese Han ovarian cancer.
Sanger sequencing was used to analyze the PIK3CA rs2699887, rs3976507, rs6443626 genotypes in 350 Chinese Han ovarian cancer patients and 350 control individuals, and the expression of PIK3CA protein was detected in 117 ovarian cancer patients.
In subjects with age ≥60 years, Number liveborn ≤ 3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of the rs2699887 T allele carriers were increased (all p < 0.05). In subjects with obesity (BMI ≥ 24 kg/m2), Number liveborn ≤3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of rs3976507 T allele carriers and rs6443626 C allele carriers were increased (all p < 0.05). PIK3CA protein expression level in PIK3CA rs2699887 C > T, rs3976507 C > T, rs6443626 T > C locus homozygotes was significantly higher than that in heterozygotes (p < 0.05).
Interaction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk. Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk. |
---|---|
AbstractList | The PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are found in a variety of human cancers. This study aimed to analyze the effect of interactions between PIK3CA rs2699887, rs3976507, rs6443626 single nucleotide polymorphisms (SNPs), and the environment on the risk of Chinese Han ovarian cancer.BACKGROUND AND PURPOSEThe PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are found in a variety of human cancers. This study aimed to analyze the effect of interactions between PIK3CA rs2699887, rs3976507, rs6443626 single nucleotide polymorphisms (SNPs), and the environment on the risk of Chinese Han ovarian cancer.Sanger sequencing was used to analyze the PIK3CA rs2699887, rs3976507, rs6443626 genotypes in 350 Chinese Han ovarian cancer patients and 350 control individuals, and the expression of PIK3CA protein was detected in 117 ovarian cancer patients.METHODSSanger sequencing was used to analyze the PIK3CA rs2699887, rs3976507, rs6443626 genotypes in 350 Chinese Han ovarian cancer patients and 350 control individuals, and the expression of PIK3CA protein was detected in 117 ovarian cancer patients.In subjects with age ≥60 years, Number liveborn ≤ 3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of the rs2699887 T allele carriers were increased (all p < 0.05). In subjects with obesity (BMI ≥ 24 kg/m2), Number liveborn ≤3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of rs3976507 T allele carriers and rs6443626 C allele carriers were increased (all p < 0.05). PIK3CA protein expression level in PIK3CA rs2699887 C > T, rs3976507 C > T, rs6443626 T > C locus homozygotes was significantly higher than that in heterozygotes (p < 0.05).RESULTSIn subjects with age ≥60 years, Number liveborn ≤ 3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of the rs2699887 T allele carriers were increased (all p < 0.05). In subjects with obesity (BMI ≥ 24 kg/m2), Number liveborn ≤3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of rs3976507 T allele carriers and rs6443626 C allele carriers were increased (all p < 0.05). PIK3CA protein expression level in PIK3CA rs2699887 C > T, rs3976507 C > T, rs6443626 T > C locus homozygotes was significantly higher than that in heterozygotes (p < 0.05).Interaction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk. Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk.CONCLUSIONInteraction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk. Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk. The PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are found in a variety of human cancers. This study aimed to analyze the effect of interactions between PIK3CA rs2699887, rs3976507, rs6443626 single nucleotide polymorphisms (SNPs), and the environment on the risk of Chinese Han ovarian cancer. Sanger sequencing was used to analyze the PIK3CA rs2699887, rs3976507, rs6443626 genotypes in 350 Chinese Han ovarian cancer patients and 350 control individuals, and the expression of PIK3CA protein was detected in 117 ovarian cancer patients. In subjects with age ≥60 years, Number liveborn ≤ 3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of the rs2699887 T allele carriers were increased (all p < 0.05). In subjects with obesity (BMI ≥ 24 kg/m2), Number liveborn ≤3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of rs3976507 T allele carriers and rs6443626 C allele carriers were increased (all p < 0.05). PIK3CA protein expression level in PIK3CA rs2699887 C > T, rs3976507 C > T, rs6443626 T > C locus homozygotes was significantly higher than that in heterozygotes (p < 0.05). Interaction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk. Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk. |
ArticleNumber | 152520 |
Author | Zhou, Li Zhang, Hui |
Author_xml | – sequence: 1 givenname: Hui surname: Zhang fullname: Zhang, Hui organization: Department of Gynecology, Hangzhou Fuyang Women and Children Hospital, No. 25 Hengliangting Road, Fuyang District, Hangzhou, Zhejiang Province, China – sequence: 2 givenname: Li surname: Zhou fullname: Zhou, Li email: zhouli820704@126.com organization: Department of Gynecology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31288947$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kTtvFDEUhS0URDaBH0CDXNLMxq95iSpaAYkSCSSgtjz2NXuXGXuwvYtS8s-Z1SYNRaqrK33fKc65IGchBiDkLWdrznhztVvPaV4Lxvs1r0Ut2Auy4g3vKtZIfkZWTCpVMSm7c3KR844x1jLFX5FzyUXX9apdkb_fMPwcgYa9HSEWdEDnOD5MMc1bzBONnn69vZOba2qCo1gyxVAgGVswBvoHy5aWLVAIB0wxTBAKNQlowvyL-oWKKVMfE91sMUAGemMCjQeTcLnWBAvpNXnpzZjhzeO9JD8-ffy-uanuv3y-3VzfV1bWslSq8-1gjAcphHC9N2KoO-CiFxJ8V5tWquWpXc8G25nODcpYpYx3DeNeDlxekven3DnF33vIRU-YLYyjCRD3WQtR16rpFWML-u4R3Q8TOD0nnEx60E-1LUB7AmyKOSfw2mIxx0pKMjhqzvRxIL1b1FkfB9KngRaT_2c-hT_nfDg5sNRzQEg6W4SlO4cJbNEu4jP2P_d-qdQ |
CitedBy_id | crossref_primary_10_7717_peerj_12377 crossref_primary_10_1142_S0192415X22500239 crossref_primary_10_1016_j_scitotenv_2020_138314 crossref_primary_10_1186_s13048_021_00831_y crossref_primary_10_12677_ACM_2020_1011430 crossref_primary_10_1016_j_jhazmat_2019_121361 crossref_primary_10_3389_fonc_2021_564296 |
Cites_doi | 10.1007/s13277-016-4924-2 10.1038/nrd4204 10.1158/1055-9965.EPI-15-1039 10.1016/j.ejca.2016.04.016 10.1158/1078-0432.CCR-13-1093 10.1111/liv.13055 10.1038/onc.2015.377 10.1038/nrd2926 10.1038/ncomms12799 10.1371/journal.pgen.1003212 10.2147/OTT.S97668 10.4161/cbt.8.1.7209 10.1016/j.ygyno.2016.07.092 10.3389/fendo.2018.00402 10.1016/j.pharmthera.2017.02.037 10.1371/journal.pone.0158801 10.1007/s00280-018-3543-6 10.1016/j.ygyno.2017.10.001 10.1016/S1535-6108(03)00248-4 10.1016/j.ijgo.2007.11.004 10.1126/science.296.5573.1655 10.1158/1055-9965.EPI-17-0315 10.1242/jcs.013029 10.18632/oncotarget.25513 10.1002/gepi.21921 10.1158/1055-9965.EPI-12-1030-T 10.1158/1078-0432.CCR-04-2142 |
ContentType | Journal Article |
Copyright | 2019 Copyright © 2019. Published by Elsevier GmbH. |
Copyright_xml | – notice: 2019 – notice: Copyright © 2019. Published by Elsevier GmbH. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.prp.2019.152520 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1618-0631 |
ExternalDocumentID | 31288947 10_1016_j_prp_2019_152520 S0344033819300810 |
Genre | Journal Article |
GroupedDBID | --- --K --M .55 .GJ .~1 0R~ 123 1B1 1~. 1~5 29O 3O- 3V. 4.4 457 4CK 4G. 53G 5RE 5VS 7-5 71M 7X7 88E 88I 8AF 8FE 8FH 8FI 8FJ 8G5 8P~ 8R4 8R5 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AAKPP AALRI AAOAW AAQFI AAQXK AAXUO ABBQC ABFNM ABGSF ABLJU ABLVK ABMAC ABMZM ABUDA ABUWG ABXDB ABYKQ ACDAQ ACGFO ACGFS ACGOD ACPRK ACRLP ADBBV ADEZE ADKUU ADMUD ADUVX AEBSH AEHWI AEKER AENEX AFKRA AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AHMBA AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN AZQEC BBNVY BCR BCU BEC BENPR BHPHI BKOJK BLC BLXMC BNPGV BPHCQ BVXVI CAG CCPQU COF CS3 DOVZS DU5 DWQXO EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ IHE J1W K-O KOM L7B LCYCR LK8 M1P M2O M2P M2Q M41 M7P MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PADUT PC. PEA PQQKQ PRG PROAC PSQYO Q2X Q38 R2- RIG ROL RPZ S0X SDF SDG SES SEW SJFOW SSH SSU SSZ T5I T5J T5K UDS UKHRP X7M YCJ ZA5 ZGI ZXP ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACIEU ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ALIPV ANKPU CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c353t-48f7baafe3222d9fa2b58e12923ef85a7341295d90bc8a8db4ac44afd601f3b13 |
IEDL.DBID | .~1 |
ISSN | 0344-0338 1618-0631 |
IngestDate | Fri Jul 11 01:33:32 EDT 2025 Thu Apr 03 07:05:35 EDT 2025 Thu Apr 24 23:07:36 EDT 2025 Tue Jul 01 02:16:16 EDT 2025 Fri Feb 23 02:22:01 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Single nucleotide polymorphism PIK3CA Gene-environment interaction Ovarian cancer |
Language | English |
License | Copyright © 2019. Published by Elsevier GmbH. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c353t-48f7baafe3222d9fa2b58e12923ef85a7341295d90bc8a8db4ac44afd601f3b13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 31288947 |
PQID | 2255469400 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2255469400 pubmed_primary_31288947 crossref_citationtrail_10_1016_j_prp_2019_152520 crossref_primary_10_1016_j_prp_2019_152520 elsevier_sciencedirect_doi_10_1016_j_prp_2019_152520 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2019 2019-09-00 2019-Sep 20190901 |
PublicationDateYYYYMMDD | 2019-09-01 |
PublicationDate_xml | – month: 09 year: 2019 text: September 2019 |
PublicationDecade | 2010 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Pathology, research and practice |
PublicationTitleAlternate | Pathol Res Pract |
PublicationYear | 2019 |
Publisher | Elsevier GmbH |
Publisher_xml | – name: Elsevier GmbH |
References | Huang (bib0005) 2016; 63 Couch (bib0070) 2013; 9 Lee (bib0105) 2016; 7 Usset (bib0140) 2016; 25 Luo, Manning, Cantley (bib0090) 2003; 4 He (bib0040) 2016; 9 Kar (bib0015) 2018; 27 Amankwah (bib0075) 2015; 39 Le Naour (bib0100) 2018; 9 Vigorito (bib0080) 2016; 11 Astanehe (bib0135) 2008; 121 Fruman, Rommel (bib0055) 2014; 13 Odicino (bib0065) 2008; 101 Cheng (bib0115) 2016; 35 Cantley (bib0025) 2002; 296 Jones (bib0010) 2017; 147 Nicos (bib0035) 2016; 36 Citi (bib0120) 2018; 81 Wang (bib0045) 2016; 142 Dirican, Akkiprik, Ozer (bib0030) 2016; 37 Li (bib0125) 2013; 19 Wang (bib0110) 2016; 36 Kolasa (bib0130) 2009; 8 Liu (bib0050) 2009; 8 Dey, De, Leyland-Jones (bib0095) 2017; 175 Levine (bib0085) 2005; 11 Pearce (bib0020) 2013; 22 O’Brien (bib0060) 2018; 9 Nicos (10.1016/j.prp.2019.152520_bib0035) 2016; 36 Kar (10.1016/j.prp.2019.152520_bib0015) 2018; 27 He (10.1016/j.prp.2019.152520_bib0040) 2016; 9 Astanehe (10.1016/j.prp.2019.152520_bib0135) 2008; 121 Usset (10.1016/j.prp.2019.152520_bib0140) 2016; 25 Couch (10.1016/j.prp.2019.152520_bib0070) 2013; 9 Fruman (10.1016/j.prp.2019.152520_bib0055) 2014; 13 Luo (10.1016/j.prp.2019.152520_bib0090) 2003; 4 Jones (10.1016/j.prp.2019.152520_bib0010) 2017; 147 Le Naour (10.1016/j.prp.2019.152520_bib0100) 2018; 9 Citi (10.1016/j.prp.2019.152520_bib0120) 2018; 81 Wang (10.1016/j.prp.2019.152520_bib0110) 2016; 36 O’Brien (10.1016/j.prp.2019.152520_bib0060) 2018; 9 Dey (10.1016/j.prp.2019.152520_bib0095) 2017; 175 Huang (10.1016/j.prp.2019.152520_bib0005) 2016; 63 Liu (10.1016/j.prp.2019.152520_bib0050) 2009; 8 Amankwah (10.1016/j.prp.2019.152520_bib0075) 2015; 39 Wang (10.1016/j.prp.2019.152520_bib0045) 2016; 142 Lee (10.1016/j.prp.2019.152520_bib0105) 2016; 7 Levine (10.1016/j.prp.2019.152520_bib0085) 2005; 11 Cheng (10.1016/j.prp.2019.152520_bib0115) 2016; 35 Li (10.1016/j.prp.2019.152520_bib0125) 2013; 19 Cantley (10.1016/j.prp.2019.152520_bib0025) 2002; 296 Kolasa (10.1016/j.prp.2019.152520_bib0130) 2009; 8 Vigorito (10.1016/j.prp.2019.152520_bib0080) 2016; 11 Odicino (10.1016/j.prp.2019.152520_bib0065) 2008; 101 Dirican (10.1016/j.prp.2019.152520_bib0030) 2016; 37 Pearce (10.1016/j.prp.2019.152520_bib0020) 2013; 22 |
References_xml | – volume: 63 start-page: 1 year: 2016 end-page: 10 ident: bib0005 article-title: Incidence and mortality of gynaecological cancers: secular trends in urban Shanghai, China over 40 years publication-title: Eur. J. Cancer – volume: 36 start-page: 2243 year: 2016 end-page: 2249 ident: bib0035 article-title: PIK3CA mutations detected in patients with central nervous system metastases of non-small cell lung cancer publication-title: Anticancer Res. – volume: 19 start-page: 6252 year: 2013 end-page: 6260 ident: bib0125 article-title: Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer publication-title: Clin. Cancer Res. – volume: 36 start-page: 1176 year: 2016 end-page: 1186 ident: bib0110 article-title: Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade publication-title: Liver Int. – volume: 22 start-page: 880 year: 2013 end-page: 890 ident: bib0020 article-title: Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer publication-title: Cancer Epidemiol. Biomarkers Prev. – volume: 147 start-page: 705 year: 2017 end-page: 713 ident: bib0010 article-title: Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction publication-title: Gynecol. Oncol. – volume: 13 start-page: 140 year: 2014 end-page: 156 ident: bib0055 article-title: PI3K and cancer: lessons, challenges and opportunities publication-title: Nat. Rev. Drug Discov. – volume: 4 start-page: 257 year: 2003 end-page: 262 ident: bib0090 article-title: Targeting the PI3K-Akt pathway in human cancer: rationale and promise publication-title: Cancer Cell – volume: 9 start-page: 402 year: 2018 ident: bib0060 article-title: Overview of MicroRNA biogenesis, mechanisms of actions, and circulation publication-title: Front. Endocrinol. (Lausanne) – volume: 27 start-page: 395 year: 2018 end-page: 404 ident: bib0015 article-title: Common genetic variation and susceptibility to ovarian cancer: current insights and future directions publication-title: Cancer Epidemiol. Biomarkers Prev. – volume: 37 start-page: 7033 year: 2016 end-page: 7045 ident: bib0030 article-title: Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer publication-title: Tumour Biol. – volume: 11 start-page: 2875 year: 2005 end-page: 2878 ident: bib0085 article-title: Frequent mutation of the PIK3CA gene in ovarian and breast cancers publication-title: Clin. Cancer Res. – volume: 8 start-page: 21 year: 2009 end-page: 26 ident: bib0130 article-title: PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients publication-title: Cancer Biol. Ther. – volume: 142 start-page: 548 year: 2016 end-page: 556 ident: bib0045 article-title: Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes publication-title: Gynecol. Oncol. – volume: 121 start-page: 664 year: 2008 end-page: 674 ident: bib0135 article-title: Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer publication-title: J. Cell. Sci. – volume: 175 start-page: 91 year: 2017 end-page: 106 ident: bib0095 article-title: PI3K-AKT-mTOR inhibitors in breast cancers: from tumor cell signaling to clinical trials publication-title: Pharmacol. Ther. – volume: 11 year: 2016 ident: bib0080 article-title: Fine-scale mapping at 9p22.2 identifies candidate causal variants that modify ovarian cancer risk in BRCA1 and BRCA2 mutation carriers publication-title: PLoS One – volume: 9 start-page: 2329 year: 2016 end-page: 2335 ident: bib0040 article-title: Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer publication-title: Onco. Ther. – volume: 35 start-page: 2961 year: 2016 end-page: 2970 ident: bib0115 article-title: PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling publication-title: Oncogene – volume: 8 start-page: 627 year: 2009 end-page: 644 ident: bib0050 article-title: Targeting the phosphoinositide 3-kinase pathway in cancer publication-title: Nat. Rev. Drug Discov. – volume: 25 start-page: 780 year: 2016 end-page: 790 ident: bib0140 article-title: Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors publication-title: Cancer Epidemiol. Biomarkers Prev. – volume: 39 start-page: 689 year: 2015 end-page: 697 ident: bib0075 article-title: Epithelial-mesenchymal transition (EMT) gene variants and epithelial ovarian cancer (EOC) risk publication-title: Genet. Epidemiol. – volume: 296 start-page: 1655 year: 2002 end-page: 1657 ident: bib0025 article-title: The phosphoinositide 3-kinase pathway publication-title: Science – volume: 81 start-page: 745 year: 2018 end-page: 754 ident: bib0120 article-title: Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro publication-title: Cancer Chemother. Pharmacol. – volume: 9 year: 2013 ident: bib0070 article-title: Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk publication-title: PLoS Genet. – volume: 7 start-page: 12799 year: 2016 ident: bib0105 article-title: Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis publication-title: Nat. Commun. – volume: 9 start-page: 27220 year: 2018 end-page: 27232 ident: bib0100 article-title: Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance publication-title: Oncotarget – volume: 101 start-page: 205 year: 2008 end-page: 210 ident: bib0065 article-title: History of the FIGO cancer staging system publication-title: Int. J. Gynaecol. Obstet. – volume: 37 start-page: 7033 issue: 6 year: 2016 ident: 10.1016/j.prp.2019.152520_bib0030 article-title: Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer publication-title: Tumour Biol. doi: 10.1007/s13277-016-4924-2 – volume: 13 start-page: 140 issue: 2 year: 2014 ident: 10.1016/j.prp.2019.152520_bib0055 article-title: PI3K and cancer: lessons, challenges and opportunities publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4204 – volume: 25 start-page: 780 issue: 5 year: 2016 ident: 10.1016/j.prp.2019.152520_bib0140 article-title: Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors publication-title: Cancer Epidemiol. Biomarkers Prev. doi: 10.1158/1055-9965.EPI-15-1039 – volume: 63 start-page: 1 year: 2016 ident: 10.1016/j.prp.2019.152520_bib0005 article-title: Incidence and mortality of gynaecological cancers: secular trends in urban Shanghai, China over 40 years publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2016.04.016 – volume: 19 start-page: 6252 issue: 22 year: 2013 ident: 10.1016/j.prp.2019.152520_bib0125 article-title: Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-13-1093 – volume: 36 start-page: 1176 issue: 8 year: 2016 ident: 10.1016/j.prp.2019.152520_bib0110 article-title: Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade publication-title: Liver Int. doi: 10.1111/liv.13055 – volume: 36 start-page: 2243 issue: 5 year: 2016 ident: 10.1016/j.prp.2019.152520_bib0035 article-title: PIK3CA mutations detected in patients with central nervous system metastases of non-small cell lung cancer publication-title: Anticancer Res. – volume: 35 start-page: 2961 issue: 23 year: 2016 ident: 10.1016/j.prp.2019.152520_bib0115 article-title: PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling publication-title: Oncogene doi: 10.1038/onc.2015.377 – volume: 8 start-page: 627 issue: 8 year: 2009 ident: 10.1016/j.prp.2019.152520_bib0050 article-title: Targeting the phosphoinositide 3-kinase pathway in cancer publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2926 – volume: 7 start-page: 12799 year: 2016 ident: 10.1016/j.prp.2019.152520_bib0105 article-title: Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis publication-title: Nat. Commun. doi: 10.1038/ncomms12799 – volume: 9 issue: 3 year: 2013 ident: 10.1016/j.prp.2019.152520_bib0070 article-title: Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1003212 – volume: 9 start-page: 2329 year: 2016 ident: 10.1016/j.prp.2019.152520_bib0040 article-title: Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer publication-title: Onco. Ther. doi: 10.2147/OTT.S97668 – volume: 8 start-page: 21 issue: 1 year: 2009 ident: 10.1016/j.prp.2019.152520_bib0130 article-title: PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients publication-title: Cancer Biol. Ther. doi: 10.4161/cbt.8.1.7209 – volume: 142 start-page: 548 issue: 3 year: 2016 ident: 10.1016/j.prp.2019.152520_bib0045 article-title: Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2016.07.092 – volume: 9 start-page: 402 year: 2018 ident: 10.1016/j.prp.2019.152520_bib0060 article-title: Overview of MicroRNA biogenesis, mechanisms of actions, and circulation publication-title: Front. Endocrinol. (Lausanne) doi: 10.3389/fendo.2018.00402 – volume: 175 start-page: 91 year: 2017 ident: 10.1016/j.prp.2019.152520_bib0095 article-title: PI3K-AKT-mTOR inhibitors in breast cancers: from tumor cell signaling to clinical trials publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2017.02.037 – volume: 11 issue: 7 year: 2016 ident: 10.1016/j.prp.2019.152520_bib0080 article-title: Fine-scale mapping at 9p22.2 identifies candidate causal variants that modify ovarian cancer risk in BRCA1 and BRCA2 mutation carriers publication-title: PLoS One doi: 10.1371/journal.pone.0158801 – volume: 81 start-page: 745 issue: 4 year: 2018 ident: 10.1016/j.prp.2019.152520_bib0120 article-title: Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro publication-title: Cancer Chemother. Pharmacol. doi: 10.1007/s00280-018-3543-6 – volume: 147 start-page: 705 issue: 3 year: 2017 ident: 10.1016/j.prp.2019.152520_bib0010 article-title: Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2017.10.001 – volume: 4 start-page: 257 issue: 4 year: 2003 ident: 10.1016/j.prp.2019.152520_bib0090 article-title: Targeting the PI3K-Akt pathway in human cancer: rationale and promise publication-title: Cancer Cell doi: 10.1016/S1535-6108(03)00248-4 – volume: 101 start-page: 205 issue: 2 year: 2008 ident: 10.1016/j.prp.2019.152520_bib0065 article-title: History of the FIGO cancer staging system publication-title: Int. J. Gynaecol. Obstet. doi: 10.1016/j.ijgo.2007.11.004 – volume: 296 start-page: 1655 issue: 5573 year: 2002 ident: 10.1016/j.prp.2019.152520_bib0025 article-title: The phosphoinositide 3-kinase pathway publication-title: Science doi: 10.1126/science.296.5573.1655 – volume: 27 start-page: 395 issue: 4 year: 2018 ident: 10.1016/j.prp.2019.152520_bib0015 article-title: Common genetic variation and susceptibility to ovarian cancer: current insights and future directions publication-title: Cancer Epidemiol. Biomarkers Prev. doi: 10.1158/1055-9965.EPI-17-0315 – volume: 121 start-page: 664 issue: Pt 5 year: 2008 ident: 10.1016/j.prp.2019.152520_bib0135 article-title: Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer publication-title: J. Cell. Sci. doi: 10.1242/jcs.013029 – volume: 9 start-page: 27220 issue: 43 year: 2018 ident: 10.1016/j.prp.2019.152520_bib0100 article-title: Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance publication-title: Oncotarget doi: 10.18632/oncotarget.25513 – volume: 39 start-page: 689 issue: 8 year: 2015 ident: 10.1016/j.prp.2019.152520_bib0075 article-title: Epithelial-mesenchymal transition (EMT) gene variants and epithelial ovarian cancer (EOC) risk publication-title: Genet. Epidemiol. doi: 10.1002/gepi.21921 – volume: 22 start-page: 880 issue: 5 year: 2013 ident: 10.1016/j.prp.2019.152520_bib0020 article-title: Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer publication-title: Cancer Epidemiol. Biomarkers Prev. doi: 10.1158/1055-9965.EPI-12-1030-T – volume: 11 start-page: 2875 issue: 8 year: 2005 ident: 10.1016/j.prp.2019.152520_bib0085 article-title: Frequent mutation of the PIK3CA gene in ovarian and breast cancers publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-04-2142 |
SSID | ssj0007041 |
Score | 2.2374053 |
Snippet | The PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 152520 |
SubjectTerms | Adult Aged Aged, 80 and over Alcohol Drinking - adverse effects Asian Continental Ancestry Group Class I Phosphatidylinositol 3-Kinases - genetics Female Gene-Environment Interaction Humans Middle Aged Obesity - complications Ovarian cancer Ovarian Neoplasms - genetics Parity PIK3CA Polymorphism, Single Nucleotide Risk Factors Single nucleotide polymorphism Smoking - adverse effects |
Title | Single nucleotide polymorphism of PIK3CA and its interaction with the environment are risk factors for Chinese Han ovarian cancer |
URI | https://dx.doi.org/10.1016/j.prp.2019.152520 https://www.ncbi.nlm.nih.gov/pubmed/31288947 https://www.proquest.com/docview/2255469400 |
Volume | 215 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhhdJL6bvbR5hCTwV37ZVkWcdladg0JBTSQG5CskfgsrWXXafHQv95Z_xIW2hz6MnYSNhoxjPfaEbzCfFW-ywzobRJzFOfKI8h8UWOiQ8hZtJkaCrehzw7z9eX6uOVvjoQq-ksDJdVjrZ_sOm9tR6fzMfVnG_ren7BzepSyRGHZMfGcbtShrX8_fdfZR4m7dkreXDCo6fMZl_jte1bVma2ZwFiyu-_-6Z_Yc_eBx0_EPdH8AjL4fseigNsHom7Z2N6_LH4cUGOaIPQcJPitqsrhG27oeieFrPef4U2wqeTU7lagm8qqLs9cLeI3XC2AXhLFggPwm-H38DvELj8HEZiHiCQC0y6jXuEtW-g_UbRNl1LVp_dE3F5_OHzap2MHAtJKbXsElVEE7yPyBmXyka_CLpAAgELibHQ3pCXW1hd2TSUhS-qoHyplI8VBXJRhkw-FYdN2-BzAZHRU26twZJgIIkkeJ1jtNrmaHCBM5FOq-vKsQE582Bs3FRp9sWRQBwLxA0CmYl3N1O2Q_eN2warSWTuDxVy5B1um_ZmEq-jX4vzJb7B9nrvyNRplTNz_Ew8G-R-8xWS_HphlXnxfy99Ke7x3VCs9kocdrtrfE3opgtHvfoeiTvLk9P1-U9hdPmK |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhgbaXkD6zfU6hp4K79kqyrWNYGjZNNhSSQG5CskfgsrWXXafHQv95Z_xIW2hz6MlgS1hopJlvNKP5hHinXZJkvjBRSGMXKYc-cnmKkfM-JDJLMCv5HHJ5ni6u1Kdrfb0j5uNdGE6rHHR_r9M7bT28mQ6zOV1X1fSCi9XFkj0OyYaN_PY9RduXaQw-fP-V55HFHX0lt464-Rja7JK81l3NysR0NEDM-f134_Qv8NkZoeMDsT-gRzjqB_hQ7GD9SNxbDvHxx-LHBVmiFULNVYqbtioR1s2K3HuazWr7FZoAn09O5fwIXF1C1W6By0Vs-ssNwGeyQIAQfrv9Bm6DwPnnMDDzAKFcYNZt3CIsXA3NN3K36Vnw-tk8EVfHHy_ni2ggWYgKqWUbqTxk3rmAHHIpTXAzr3MkFDCTGHLtMjJzM6NLE_sid3nplSuUcqEkTy5In8inYrduajwUEBg-pcZkWBAOJJl4p1MMRpsUM5zhRMTj7NpiqEDORBgrO6aafbEkEMsCsb1AJuL9bZd1X37jrsZqFJn9Yw1ZMg93dXs7itfS3uKAiauxudla0nVapUwdPxHPernfjkKSYc-Nyp7_30_fiPuLy-WZPTs5P30hHvCXPnPtpdhtNzf4iqBO6193S_knDqb7GA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single+nucleotide+polymorphism+of+PIK3CA+and+its+interaction+with+the+environment+are+risk+factors+for+Chinese+Han+ovarian+cancer&rft.jtitle=Pathology%2C+research+and+practice&rft.au=Zhang%2C+Hui&rft.au=Zhou%2C+Li&rft.date=2019-09-01&rft.eissn=1618-0631&rft.volume=215&rft.issue=9&rft.spage=152520&rft_id=info:doi/10.1016%2Fj.prp.2019.152520&rft_id=info%3Apmid%2F31288947&rft.externalDocID=31288947 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0344-0338&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0344-0338&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0344-0338&client=summon |